Antifungal activities of compounds isolated from Piper abutiloides Kunth

Mycoses

Volumn 52, Issue 6, 2009, Pages 499-506

  Johann, S ^a   Cota, B B ^a   Souza Fagundes, E M ^a   Pizzolatti, M G ^b   Resende, M A ^a   Zani, C L ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

Author keywords

Antifungal; Conocarpan; Eupomatenoid 6; Piper abutiloides; Pseudodillapiol

Indexed keywords

AMPHOTERICIN; ANTIFUNGAL AGENT; CONOCARPAN; EUPOMATENOID 6; HEXANE; METHANOL; PHYTOHEMAGGLUTININ; PIPER ABUTILOIDES EXTRACT; PLANT EXTRACT; PSEUDODILLAPIOL; UNCLASSIFIED DRUG;

ANTIFUNGAL ACTIVITY; AQUEOUS SOLUTION; ARTICLE; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA KRUSEI; CANDIDA PARAPSILOSIS; CANDIDA TROPICALIS; CONTROLLED STUDY; CRYPTOCOCCUS NEOFORMANS; CYTOTOXICITY; DRUG ISOLATION; DRUG MECHANISM; DRUG SAFETY; FEMALE; HUMAN; HUMAN CELL; LYMPHOCYTE; MALE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PIPER ABUTILOIDES; PIPERACEAE; PRIORITY JOURNAL; SPOROTHRIX SCHENCKII;

ADULT; ANTIFUNGAL AGENTS; BENZOFURANS; CANDIDA ALBICANS; CHEMICAL FRACTIONATION; CHROMATOGRAPHY; CRYPTOCOCCUS NEOFORMANS; FEMALE; HUMANS; LEUKOCYTES, MONONUCLEAR; MALE; MICROBIAL SENSITIVITY TESTS; PHENOLS; PIPER; PLANT EXTRACTS; SPOROTHRIX; YOUNG ADULT;

CANDIDA ALBICANS; FILOBASIDIELLA NEOFORMANS; FUNGI; PIPERACEAE; SPOROTHRIX SCHENCKII;

EID: 70350632921     PISSN: 09337407     EISSN: 14390507     Source Type: Journal    
DOI: 10.1111/j.1439-0507.2008.01636.x     Document Type: Article

References (28)

1. Rios JL, Recio MC, Villar A. Screening methods for natural products with antimicrobial activity: a review of literature. J Ethnopharmacol 1988 23 : 127 149.
2. Gibbons S. An overview of plant extracts as potential therapeutics. Expert Opin Ther Pat 2003 13 : 489 497.
3. Nair MG, Burke BA. Antimicrobial Piper metabolite and related compounds. J Agric Food Chem 1990 38 : 1093 1096.
4. Pessini GL, Dias BPF, Nakamura CV, Cortez DAG. Antibacterial activity of extracts and neolignans from Piper regnellii (Miq.) C. DC. var. pallescens (C. DC.) Yunck. Mem Inst Oswaldo Cruz 2003 98 : 1115 1120.
5. Reddy AV, Srinivas PV, Praveen B et al. Antibacterial constituents from the berries of Piper nigrum. Phytomedicine 2004 11 : 697 700.
6. Pohlit AM, Pinto ACS, Mause R. Pluripotente plant and important phytochemical substance source. Rev Fitos 2006 2 : 7 18.
7. Campos MP, Cechinel VF, Silva RZ et al. Evalution of antifungal activity of Piper solmsianum C.DC.var solmsianum (Piperaceae). Biol Pharm Bull 2005 8 : 1527 1530.
8. Costa M, Di Stasi LC, Kirizawa M, Mendacolli SL, Gomes C, Trolin G. Screening in mice of some medicinal plants used for analgesic purposes in the state of Sao Paulo. Part II. J Ethnopharmacol 1989 27 : 25 33.
9. Johann S, Pizzolatti MG, Resende MA. Proceedings of the 23th Annual Meeting of the Brazilian Microbiology, Santos, Brazil 01-740-1. São Paulo, Brazil : Brazilian Society for Microbiology, 2005.
10. Pfaller MA, Zhang J, Messer SA et al. In vitro activities of voriconazole, fluconazole, and itraconazole against 566 clinical isolates of Cryptococcus neoformans from the United States and Africa. Antimicrob Agents Chemother 1999 43 : 169 171.
11. Clinical and Laboratory Standards Institute (CLSI). Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts. Approved standard M27-A2, 2nd edn. Wayne, PA : National Committee for Clinical Laboratory Standards, 2002.
12. Johann S, Soldi C, Lyon JP, Pizzolatti MG, Resende MA. Antifungal activity of the amyrin derivatives and in vitro inhibition of Candida albicans adhesion to human epithelial cells. Lett Appl Microbiol 2007 45 : 148 153.
13. Rahalison L, Hamburger M, Monod M, Frenk E, Hostettman K. Antifungal tests in phytochemical investigations: comparison of bioautographic methods using phytopathogenic and human pathogenic fungi. Plant Med 1994 60 : 41 4.
14. Greger H, Zechner G, Hofer O, Hadacek F, Wurz G. Sulphur-containing amides from Glycosmis species with different antifungal activity. Phytochemistry 1993 34 : 175 179.
15. Salah MA, Bedir E, Toyang NG, Khan IA, Harries MD, Wedge DE. Antifungal clerodane diterpenes from Mancaranga monandra (L) Muell. et.Arg. (Euphorbiaceae). J Agric Food Chem 2003 51 : 7607 7610.
16. Jiang J, Xu Q. Immunomodulatory activity of the aqueous extract from rhizome of Smilax glabra in the later phase of adjuvant-induced arthritis in tats. J Ethnopharmacol 2003 85 : 53 9.
17. Souza-Fagundes EM, Gazzinelli G, Parreira GG et al. In vitro activity of labdane diterpene from Alomia myriadenia (Asteraceae): immunosuppression via induction of apoptosis in monocytes. Int Immunopharmacol 2003 3 : 383 392.
18. Chauret D, Bernard CB, Arnason JT, Durst T. Insecticidal neolignans from Piper decurrens. J Nat Prod 1996 59 : 152 155.
19. Anh NH, Ripperger H, Porzel A, Sung TV, Adam G. Neolignans from Caryodaphnopsis baviensis. Phytochemistry 1997 46 : 569 571.
20. Maxwell A, Dabideen D, Reynolds WF, McLean S. Neolignans from Piper aequale. Phytochemistry 1999 50 : 499 504.
21. Achenbach H, Utz W, Lozano B, Touché EMG, Moreno S. Lignans and neolignans from Krameria parvifolia. Phytochemistry 1996 43 : 1093 1095.
22. Pessini GL, Dias BP, Nakamura CV, Cortez DAG. Antifungal activity of the extracts and neolignans from Piper regnellii (Miq.) C.DC. var. pallescens (C.DC.) Yunck. J Braz Chem Soc 2005 16 : 1130 1133.
23. Valgas C, Souza SM, Smânia EFA, Smânia A Jr. Screening methods to determine antibacterial activity of natural products. Braz J Microbiol 2007 38 : 369 380.
24. Freixa B, Vila R, Ferro EA, Adzet T, Canigueral S. Antifungal principles from Piper fulvescens. Plant Med 2001 67 : 873 875.
25. Luize PS, Ueda-Nakamura T, Dias Filho BP, Cortez DAG, Nakamura CV. Activity of neolignans isolated from Piper regnellii (Miq.) C.DC. var. pallescens (C.DC.) Yunck against Trypanosoma cruzi. Biol Pharm Bull 2006 29 : 2126 2130.
26. Kromery VA, Barnes AJ. Non-albicans Candida spp. causing fungaemia: pathogenicity and antifungal resistance. J Hosp Infect 2002 50 : 243 260.
27. Li W, Lam MS, Birkeland A et al. Cell-based assays for profiling activity and safety properties of cancer drugs. J Pharmacol Toxicol Methods 2006 54 : 313 319.
28. Fidan I, Yuksel S, Imir TK, Kalkanci A, Kustimur S, Ilhan MN. The effects of fluconazole and cytokines on human mononuclear cells. Mem Inst Oswaldo Cruz 2000 12 : 127 131.